gemcitabine has been researched along with berbamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, X; Wu, Y | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
2 other study(ies) available for gemcitabine and berbamine
| Article | Year |
|---|---|
Berbamine enhances the antineoplastic activity of gemcitabine in pancreatic cancer cells by activating transforming growth factor-β/Smad signaling.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Benzylisoquinolines; Cell Cycle; Cell Line, Tumor; Cell Survival; Deoxycytidine; Down-Regulation; Drug Interactions; Gemcitabine; Humans; Pancreatic Neoplasms; Signal Transduction; Smad Proteins; Transforming Growth Factor beta | 2014 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |